157 related articles for article (PubMed ID: 9210689)
1. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Drehobl M; Bianchi P; Keyserling CH; Tack KJ; Griffin TJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1579-83. PubMed ID: 9210689
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Jiang XT; Du YP; Deng LP
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1876-8. PubMed ID: 15631797
[TBL] [Abstract][Full Text] [Related]
3. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
Leigh AP; Nemeth MA; Keyserling CH; Hotary LH; Tack KJ
Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.
Donowitz GR; Brandon ML; Salisbury JP; Harman CP; Tipping DM; Urick AE; Talbot GH
Clin Ther; 1997; 19(5):936-53. PubMed ID: 9385482
[TBL] [Abstract][Full Text] [Related]
5. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
Gwaltney JM; Savolainen S; Rivas P; Schenk P; Scheld WM; Sydnor A; Keyserling C; Leigh A; Tack KJ
Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
Fogarty CM; Bettis RB; Griffin TJ; Keyserling CH; Nemeth MA; Tack KJ
J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
[TBL] [Abstract][Full Text] [Related]
8. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Perry CM; Scott LJ
Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
[TBL] [Abstract][Full Text] [Related]
11. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
12. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
[TBL] [Abstract][Full Text] [Related]
13. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
[TBL] [Abstract][Full Text] [Related]
14. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
Guay DR
Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Nicholson SC; Welte T; File TM; Strauss RS; Michiels B; Kaul P; Balis D; Arbit D; Amsler K; Noel GJ
Int J Antimicrob Agents; 2012 Mar; 39(3):240-6. PubMed ID: 22230331
[TBL] [Abstract][Full Text] [Related]
16. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
17. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.
Casali L; Voi M; Janssen CJ; Olovich KG; Dere WH
Clin Ther; 1992; 14(4):570-7. PubMed ID: 1525791
[TBL] [Abstract][Full Text] [Related]
18. A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
Badaró R; Molinar F; Seas C; Stamboulian D; Mendonça J; Massud J; Nascimento LO;
Braz J Infect Dis; 2002 Oct; 6(5):206-18. PubMed ID: 12495602
[TBL] [Abstract][Full Text] [Related]
19. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
[TBL] [Abstract][Full Text] [Related]
20. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
